CLINICAL TRIAL SUMMARY

MDACC Study No:ID01-022 (clinicaltrials.gov NCT No: NCT00539162)
Title:Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Principal Investigator:Karen H. Lu
Treatment Agent:None
Study Status:Open
Study Description:The goal of this clinical research study is to evaluate a method involving a
blood test, called CA-125, that may be helpful in the early detection of
ovarian cancer in post-menopausal women.

Hide details for General InformationGeneral Information

Disease Group:Other Studies
Phase of Study:N/A
Treatment Agents:None
Treatment Location:Independent Multicenter Arrangements
Estimated Length of Stay in Houston:None
Supported By:N/A
Return Visit:Return visits depend on the results of each woman's algorithm. See full
protocol for details
Home Care:none


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Karen H. Lu
Dept:Gynecologic Oncology
For Clinical Trial Enrollment:713-563-4579
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults